FDA
approval
· 2023-07-21
FDA Approved: YCANTH — Original Application (Verrica Pharmaceuticals Inc.)
Summary
FDA approved YCANTH (cantharidin) from Verrica Pharmaceuticals in an Original Application (NDA 212905) for the topical treatment of common warts (verruca vulgar…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for YCANTH (CANTHARIDIN)